Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation-Reference-Cited by-同舟云学术

Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation

Published:2008-10 Issue:4 Volume:374 Page:683-687
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Noman Abu Shadat M.,Koide Naoki,Khuda Imtiaz I.-E.,Dagvadorj Jargalsaikhan,Tumurkhuu Gantsetseg,Naiki Yoshikazu,Komatsu Takayuki,Yoshida Tomoaki,Yokochi Takashi

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference36 articles.

1. Antitumor activity of thalidomide in refractory multiple myeloma;Singhal;N. Engl. J. Med.,1999

2. Continuous low dose thalidomide: a Phase II study in advanced melanoma, renal cell, ovarian and breast cancer;Eisen;Br. J. Cancer,2000

3. Thalidomide for malignant melanoma;Kudva;N. Engl. J. Med.,2001

4. Thalidomide in the treatment of Kaposi’s sarcoma;Rubegni;Dermatology,2007

5. An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer;Drake;Br. J. Cancer,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms;Frontiers in Immunology;2022-10-12

2. Interactions Between Anti-Angiogenic Therapy and Immunotherapy in Glioblastoma;Frontiers in Oncology;2022-01-12

3. Palladium (II) complex and thalidomide intercept angiogenic signaling via targeting FAK/Src and Erk/Akt/PLCγ dependent autophagy pathways in human umbilical vein endothelial cells;Microvascular Research;2021-11

4. A Case of Lenalidomide-Associated Papulopustular Rash: Beyond the Epidermal Growth Factor Receptor Inhibitor Spectrum;American Journal of Therapeutics;2020-03-19

5. Synergistic Inhibition of Thalidomide and Icotinib on Human Non-Small Cell Lung Carcinomas Through ERK and AKT Signaling;Medical Science Monitor;2018-05-15